Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) declared a dividend on Monday, March 10th, NASDAQ Dividends reports. Stockholders of record on Monday, April 7th will be paid a dividend of 0.3758 per share by the biotechnology company on Wednesday, April 23rd. The ex-dividend date of this dividend is Monday, April 7th. This is a 123.9% increase from Novozymes A/S’s previous dividend of $0.17.
Novozymes A/S Price Performance
Shares of OTCMKTS NVZMY opened at $58.96 on Wednesday. Novozymes A/S has a one year low of $52.96 and a one year high of $72.50. The stock has a market capitalization of $27.61 billion, a PE ratio of 37.32, a P/E/G ratio of 3.87 and a beta of 0.91. The business’s fifty day moving average price is $57.09 and its 200-day moving average price is $61.27.
Analyst Upgrades and Downgrades
Separately, Barclays upgraded Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th.
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Companies Buying Back Stock—Why It Matters
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Institutions Bought 3 Stocks Heavily in Q1 2025
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Beyond a Market Correction, Moves to Make Now
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.